Heart disease: A keto diet with MCT oil can help you lose extra weight, reducing your risk of heart disease
This is the most dangerous misunderstanding in semaglutide dosing
At a time when Novo Nordisk (NOVN: N) has appeared to be slipping behind rival Eli Lilly (NYSE: LLY) and its blockbuster Zepbound (tirzepatide) in the race to be the frontrunner in obesity, the Danish pharma major has fought back with some compelling data on its product Wegovy (semaglutide injection)
Semaglutide is FDA-approved for adults with a BMI of 30 or higher (obese), or a BMI of 27 or higher (overweight) with at least one weight-related health condition such as high blood pressure, type 2 diabetes, or high cholesterol
GLP-1 therapy tends to suit a patient looking for a longer-term, metabolically active option and who can manage the cost and the gradual dose schedule
The peptide cost calculator can help you compare costs across different formulations and providers